Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-11

FDA Approved: NITROFURANTOIN — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the original application for nitrofurantoin, granting a generic version from Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (Nitrofurantoin)

Snippet

ORIG AP for NITROFURANTOIN (NITROFURANTOIN)